Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

The next generation of COVID-19 vaccines could soon be here – and ... That one is a viral vector vaccine – the gene that codes for the SARS-CoV-2 spike protein is carried inside a “shell ...

COVID-19, influenza and RSV vaccines are also available ... The Johnson & Johnson vaccine, a viral vector vaccine, has expired and is no longer available in the country as of May 6, 2023.

Newly updated COVID-19 vaccines won recent approval from the ... which is to reduce the likelihood of children being a vector or a means of spread to a more vulnerable person, someone, one of ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

COVID-19 vaccines used in Brazil are from three different technology platforms. Besides Pfizer's, which contains synthetic RNA from SARS-CoV-2, there are also the viral vector vaccines ...

It doesn't enter the nucleus of the cells, where the DNA is kept. COVID-19 vaccines don't change your DNA. Also, the genetic material that's delivered with vector vaccines, such as the Johnson & ...

Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United ...

A promising Lassa fever vaccine shows potential to prevent severe disease and death in animals.

coronavirus disease 2019 (COVID-19) vaccine with that provided by a booster dose of a mucosal bivalent adenoviral vector ...